Legal & General Group Plc Grows Holdings in Cigna Group $CI

Legal & General Group Plc grew its position in Cigna Group (NYSE:CI) by 2.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,010,677 shares of the health services provider’s stock after acquiring an additional 43,351 shares during the period. Legal & General Group Plc owned about 0.75% of Cigna Group worth $579,578,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. Harbor Capital Advisors Inc. grew its holdings in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the period. Collier Financial acquired a new position in shares of Cigna Group during the 3rd quarter worth approximately $34,000. Traub Capital Management LLC purchased a new stake in Cigna Group in the 2nd quarter worth $48,000. Twin Peaks Wealth Advisors LLC acquired a new position in Cigna Group during the second quarter worth $52,000. Finally, CNB Bank raised its position in Cigna Group by 479.4% during the third quarter. CNB Bank now owns 197 shares of the health services provider’s stock worth $57,000 after acquiring an additional 163 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Price Performance

Shares of NYSE CI opened at $262.13 on Wednesday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a fifty day moving average price of $280.29 and a 200 day moving average price of $283.45. The company has a market cap of $69.08 billion, a PE ratio of 11.82, a P/E/G ratio of 0.93 and a beta of 0.27.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the company posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.4%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s payout ratio is 28.13%.

Analysts Set New Price Targets

A number of analysts have recently commented on the stock. Jefferies Financial Group boosted their target price on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Leerink Partners boosted their price objective on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. Robert W. Baird decreased their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a report on Thursday, December 11th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, TD Cowen lifted their target price on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average target price of $330.42.

Insider Activity

In related news, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.